These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 38388810)

  • 1. Diagnostic, prognostic, and therapeutic potential of exosomal microRNAs in renal cancer.
    Yu X; Du Z; Zhu P; Liao B
    Pharmacol Rep; 2024 Apr; 76(2):273-286. PubMed ID: 38388810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating exosomal microRNAs as emerging non-invasive clinical biomarkers in heart failure: Mega bio-roles of a nano bio-particle.
    Zhou R; Wang L; Zhao G; Chen D; Song X; Momtazi-Borojeni AA; Yuan H
    IUBMB Life; 2020 Dec; 72(12):2546-2562. PubMed ID: 33053610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three LHPP gene-targeting co-expressed microRNAs (microRNA-765, microRNA-21, and microRNA-144) promote proliferation, epithelial-mesenchymal transition, invasion, and are independent prognostic biomarkers in renal cell carcinomas patients.
    Meng K; Li Z; Cui X
    J Clin Lab Anal; 2021 Dec; 35(12):e24077. PubMed ID: 34699621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNAs in Serum Exosomes as Potential Biomarkers in Clear-cell Renal Cell Carcinoma.
    Zhang W; Ni M; Su Y; Wang H; Zhu S; Zhao A; Li G
    Eur Urol Focus; 2018 Apr; 4(3):412-419. PubMed ID: 28753793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stem cell-derived and circulating exosomal microRNAs as new potential tools for diabetic nephropathy management.
    Peng L; Chen Y; Shi S; Wen H
    Stem Cell Res Ther; 2022 Jan; 13(1):25. PubMed ID: 35073973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic miRNA Signatures in Paired Tumor, Plasma, and Urine Specimens From Renal Cell Carcinoma Patients.
    Bustos MA; Gottlieb J; Choe J; Suyeon R; Lin SY; Allen WM; Krasne DL; Wilson TG; Hoon DSB; Linehan JA
    Clin Chem; 2024 Jan; 70(1):261-272. PubMed ID: 37791385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNAs in the pathogenesis of renal cell carcinoma and their diagnostic and prognostic utility as cancer biomarkers.
    Fedorko M; Pacik D; Wasserbauer R; Juracek J; Varga G; Ghazal M; Nussir MI
    Int J Biol Markers; 2016 Feb; 31(1):e26-37. PubMed ID: 26481440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exosomal microRNA-1 and MYO15A as a target for therapy and diagnosis in renal cell carcinoma.
    Yoshino H; Tatarano S; Tamai M; Tsuruda M; Iizasa S; Arima J; Kawakami I; Fukumoto W; Kawahara I; Li G; Sakaguchi T; Inoguchi S; Yamada Y; Enokida H
    Biochem Biophys Res Commun; 2022 Nov; 630():71-76. PubMed ID: 36150242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of natural products versus miRNA in renal cell carcinoma: implications for disease mechanisms and diagnostic markers.
    Ayed A
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Sep; 397(9):6417-6437. PubMed ID: 38691151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The miR(21/10b) ratio as a prognostic marker in clear cell renal cell carcinoma.
    Fritz HKM; Lindgren D; Ljungberg B; Axelson H; Dahlbäck B
    Eur J Cancer; 2014 Jul; 50(10):1758-1765. PubMed ID: 24793999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Characterization of Renal Cell Carcinoma: A Potential Three-MicroRNA Prognostic Signature.
    Lokeshwar SD; Talukder A; Yates TJ; Hennig MJP; Garcia-Roig M; Lahorewala SS; Mullani NN; Klaassen Z; Kava BR; Manoharan M; Soloway MS; Lokeshwar VB
    Cancer Epidemiol Biomarkers Prev; 2018 Apr; 27(4):464-472. PubMed ID: 29440068
    [No Abstract]   [Full Text] [Related]  

  • 12. MicroRNAs as prognostic molecular signatures in renal cell carcinoma: a systematic review and meta-analysis.
    Gu L; Li H; Chen L; Ma X; Gao Y; Li X; Zhang Y; Fan Y; Zhang X
    Oncotarget; 2015 Oct; 6(32):32545-60. PubMed ID: 26416448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-566 functions as an oncogene and a potential biomarker for prognosis in renal cell carcinoma.
    Pan X; Quan J; Li Z; Zhao L; Zhou L; Jinling X; Weijie X; Guan X; Li H; Yang S; Gui Y; Lai Y
    Biomed Pharmacother; 2018 Jun; 102():718-727. PubMed ID: 29604591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating exosomal mRNA signatures for the early diagnosis of clear cell renal cell carcinoma.
    He X; Tian F; Guo F; Zhang F; Zhang H; Ji J; Zhao L; He J; Xiao Y; Li L; Wei C; Huang C; Li Y; Zhang F; Yang B; Ye H; Wang F
    BMC Med; 2022 Aug; 20(1):270. PubMed ID: 36002886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection Performance of Circulating MicroRNA-210 for Renal Cell Carcinoma: a Meta-Analysis.
    Chen Y; Wang X; Zhu X; Shao S
    Clin Lab; 2018 Apr; 64(4):569-576. PubMed ID: 29739083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exosomal microRNA-15a from ACHN cells aggravates clear cell renal cell carcinoma via the BTG2/PI3K/AKT axis.
    Li DY; Lin FF; Li GP; Zeng FC
    Kaohsiung J Med Sci; 2021 Nov; 37(11):973-982. PubMed ID: 34337864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. microRNA‑572 functions as an oncogene and a potential biomarker for renal cell carcinoma prognosis.
    Pan X; Li Z; Zhao L; Quan J; Zhou L; Xu J; Xu W; Guan X; Li H; Yang S; Gui Y; Lai Y
    Oncol Rep; 2018 Nov; 40(5):3092-3101. PubMed ID: 30132566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unlocking Precision Medicine: Liquid Biopsy Advancements in Renal Cancer Detection and Monitoring.
    Crocetto F; Falcone A; Mirto BF; Sicignano E; Pagano G; Dinacci F; Varriale D; Machiella F; Giampaglia G; Calogero A; Varlese F; Balsamo R; Trama F; Sciarra A; Del Giudice F; Busetto GM; Ferro M; Lucarelli G; Lasorsa F; Imbimbo C; Barone B
    Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RCDB: Renal Cancer Gene Database.
    Ramana J
    BMC Res Notes; 2012 May; 5():246. PubMed ID: 22608002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of dysregulated serum miR-508-3p and miR-885-5p as potential diagnostic biomarkers of clear cell renal carcinoma.
    Liu S; Deng X; Zhang J
    Mol Med Rep; 2019 Dec; 20(6):5075-5083. PubMed ID: 31661117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.